12/12/2026 08:00 AM - 12/12/2026 05:00 PM
Aspetar & QADA - National Therapeutic Use Exemption Workshop 2026
We are pleased to invite you to attend the Aspetar & QADA - National Therapeutic Use Exemption Workshop 2026, taking place online on 12 December 2026.
Identified Need:
Healthcare practitioners across all specialties may treat athletes who require medications or methods prohibited under anti-doping rules. Practitioners therefore need a clear understanding of when a Therapeutic Use Exemption (TUE) is required, the criteria for granting a TUE, and the clinical documentation needed to support an application. Education is also needed for checking the prohibited status of medications, considering permitted treatment alternatives, and managing situations where emergency treatment may require a retroactive TUE application.
The Aspetar & QADA National Therapeutic Use Exemption Workshop 2026 aims to strengthen practitioners’ knowledge and skills in these areas through practical guidance and case discussions. The workshop will support informed prescribing, complete and timely TUE applications, and coordination between treating practitioners and anti-doping authorities, helping protect athletes’ health while reducing the risk of inadvertent anti-doping rule violations.
Event: Aspetar & QADA - National Therapeutic Use Exemption Workshop 2026
Overall Learning Objectives:
On completion of this activity, participants will be able to:
- Apply the TUE criteria and identify the appropriate prospective or retroactive application pathway.
- Check medication status and assess permitted alternatives in the context of athlete care.
- Prepare a complete QADA TUE application with appropriate diagnostic evidence and treatment details.
- Identify the medical evidence needed for an ADHD TUE using WADA’s January 2026 physician guideline.
- Recognise multidisciplinary responsibilities and common documentation gaps through clinical cases.
----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
- Date: 12 December 2026
- Time: 10:00 AM – 2:00 PM
- Format of activity: Online
- Venue: Microsoft Teams – online
- Target Audience: Physicians, Allied Health Professionals, Pharmacy and Nurses
DHP accreditation statement:
This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health’s Department of Healthcare Professions - Accreditation Section and is approved for a maximum of 3.75 hours
Activity Code: Activity code: HGI-03-P202
Faculty Disclosure: It is the policy of Aspetar Orthopedic and Sports Medicine Hospital to adhere to DHP accreditation standards, and Aspetar CME CPD policies to ensure fair balance, independence, objectivity, and scientific rigor in all its CPD activities. The Scientific Planning Committee, speakers, moderators, facilitators, and/or authors participating in CPD activities are expected to disclose relevant financial relationships pertaining to their contribution to the activity. Relationship information is analyzed to determine whether conflicts of interest exist. All conflicts of interest are resolved prior to participation in the planning or implementation of this activity. Presenters and authors are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Aspetar CPD activities are intended to be evidence-based, balanced, and free of commercial bias. If you have any concerns, please contact CME/CPD Unit at 4413-2363 to anonymously express them.
Scientific Planning Committee:
Dr Omar AlSayrafi (Chair), Dr Celeste Geertsema, Dr Juan-Manuel Alonso, Dr Nohad Mohammad Al Malak, Argyro Kotsifaki, Dr Essra Zeinelabdin,
CPD Coordinator: Leonora B. Jarder
The Scientific Planning Committee has reviewed all disclosed financial relationships of speakers, moderators, facilitators, and/or authors in advance of the CPD activity and has implemented procedures to manage any potential or real conflicts of interest.
CME/CPD Unit Staff: Have nothing to disclose.
EVALUATION: An anonymous evaluation will be provided to participants at the end of each session. The evaluation allows us to assess the degree to which the activity met its objectives. It will also guide the planning of future activities and improving the educational program based on informed decisions.
Accreditation Statement.
"This activity is an Accredited Group Learning Activity (Category 1) as defined by the Ministry of Public Health’s Department of Healthcare Professions – Accreditation Section and is approved for a maximum of 3.75 hours. This CPD activity was developed in partnership with QADA.”
Click Here To Register